MAXCYTE, INC. (MXCT) — Operating Cash Flow
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$34.41M | -24.6% |
| 2024 | -$27.61M | -27.3% |
| 2023 | -$21.69M | -46.7% |
| 2022 | -$14.78M | -38.4% |
| 2021 | -$10.68M | -21.6% |
| 2020 | -$8.78M | +0.2% |
| 2019 | -$8.80M | — |
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$34.41M | -24.6% |
| 2024 | -$27.61M | -27.3% |
| 2023 | -$21.69M | -46.7% |
| 2022 | -$14.78M | -38.4% |
| 2021 | -$10.68M | -21.6% |
| 2020 | -$8.78M | +0.2% |
| 2019 | -$8.80M | — |